Zelira Therapeutics Ltd (ZLD.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2005 | 06-2004 | |
| Sales | 569 | 501 |
| Cost of Goods | 178 | 141 |
| Gross Profit | 391 | 360 |
| Operating Expenses | 861 | 1,038 |
| Operating Income | -469 | -678 |
| Interest Expense | 5 | 0 |
| Other Income | 163 | 652 |
| Pre-tax Income | -312 | -26 |
| Income Tax | -312 | -26 |
| Net Income Continuous | -312 | -26 |
| Net Income | $-312 | $0 |
| EPS Basic Total Ops | -256.68 | -22.65 |
| EPS Basic Continuous Ops | -256.68 | -22.65 |
| EPS Diluted Total Ops | -256.68 | -22.65 |
| EPS Diluted Continuous Ops | -256.68 | -22.65 |
| EBITDA(a) | $-235 | $1 |